Last $0.15 HKD
Change Today -0.004 / -2.55%
Volume 9.5M
8085 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 3:01 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

hong kong life sciences (8085) Snapshot

Open
$0.16
Previous Close
$0.16
Day High
$0.16
Day Low
$0.15
52 Week High
03/4/14 - $0.30
52 Week Low
12/10/14 - $0.13
Market Cap
604.4M
Average Volume 10 Days
21.4M
EPS TTM
$-0.04
Shares Outstanding
4.0B
EX-Date
07/4/05
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HONG KONG LIFE SCIENCES (8085)

Related News

No related news articles were found.

hong kong life sciences (8085) Related Businessweek News

No Related Businessweek News Found

hong kong life sciences (8085) Details

Hong Kong Life Sciences and Technologies Group Limited, an investment holding company, operates in the anti-aging and stem cell technology, trading, and money lending businesses in the People’s Republic of China and Hong Kong. The company offers anti-aging healthcare services, including physical examination, aging testing protocol, and stem cell storage and processing services, as well as implements anti-aging application with stem cell technology. It is also involved in the sale of electronic components, cotton yarn, and metal products; distribution of biomedical and life sciences products; provision of secured and unsecured loans for individuals and corporations; and investment and management of hotels. The company was formerly known as ZMAY Holdings Limited and changed its name to Hong Kong Life Sciences and Technologies Group Limited in October 2012. Hong Kong Life Sciences and Technologies Group Limited was incorporated in 2000 and is headquartered in Central, Hong Kong.

136 Employees
Last Reported Date: 06/25/14
Founded in 2000

hong kong life sciences (8085) Top Compensated Officers

Executive Director and Member of Remuneration...
Total Annual Compensation: $529.0K
Executive Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

hong kong life sciences (8085) Key Developments

Hong Kong Life Sciences and Technologies Group Limited Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Hong Kong Life Sciences and Technologies Group Limited reported unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the group reported loss for the period from operations and loss before tax of HKD 18,736,000 and loss for the period attributable to owners of the company of HKD 17,527,000 or 0.44 cents per diluted share on turnover of HKD 9,283,000 against loss for the period from operations and loss before tax of HKD 11,851,000 and loss for the period attributable to owners of the company of HKD 2,958,000 or 0.07 cents per diluted share on turnover of HKD 102,393,000 for the same period of last year. For the nine months, the group reported loss for the period from operations and loss before tax of HKD 69,271,000 and loss for the period attributable to owners of the company of HKD 63,485,000 or 1.61 cents per diluted share on turnover of HKD 277,204,000 against loss for the period from operations and loss before tax of HKD 20,335,000 and loss for the period attributable to owners of the company of HKD 42,484,000 or 1.18 cents per diluted share on turnover of HKD 133,805,000 for the same period of last year. The significant increase in turnover was mainly derived from the trading business. The significant increase in loss from continuing operations was mainly attributable to the held-for-trading investments incurred the realized and unrealized loss on listed securities investments.

Hong Kong Life Sciences and Technologies Group Limited to Report Q3, 2015 Results on Feb 12, 2015

Hong Kong Life Sciences and Technologies Group Limited announced that they will report Q3, 2015 results on Feb 12, 2015

Hong Kong Life Sciences and Technologies Group Limited, Board Meeting, Feb 12, 2015

Hong Kong Life Sciences and Technologies Group Limited, Board Meeting, Feb 12, 2015. Agenda: To consider and approve the unaudited consolidated results of the Company and its subsidiaries for the nine months ended December 31, 2014 and to approve the drafts announcement and report of the third quarterly results to be published on the websites of the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited and the Company; to consider the payment of an interim dividend, if any; to consider the closure of the register of members of the Company, if necessary; and to transact other business, if any.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8085:HK $0.15 HKD -0.004

8085 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8085.
View Industry Companies
 

Industry Analysis

8085

Industry Average

Valuation 8085 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HONG KONG LIFE SCIENCES, please visit www.hklifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.